Pittsburgh Patient Received Brain Implant for Opioid Addiction
Jennifer King underwent experimental surgery in late August 2026 to help manage severe opioid cravings.
Updated on Sept. 28, 2026 in Substance Abuse
Jennifer King, a 49-year-old patient, received deep brain stimulation surgery at Allegheny General Hospital in Pittsburgh in late August 2026. This procedure aims to curb opioid addiction cravings by using a precise brain implant after other treatments proved ineffective.
Why it matters
The clinical trial explores whether deep brain stimulation can successfully modulate the neural pathways associated with addiction. It offers a potential new avenue for patients who have not experienced success with standard evidence-based therapies.
The clinical trial is limited to 3 patients total, and surgeons utilize a 1.2-millimeter electrode to target the brain region where cravings originate. This follows a previous successful outcome where the first participant remained clean for 2 years.
The players
Jennifer King
She is a 49-year-old participant in an experimental clinical trial for opioid addiction.
Allegheny General Hospital
This facility is a major teaching hospital in Pittsburgh that serves as the site for the clinical trial.
Allegheny Health Network
It is a western Pennsylvania-based health system currently managing the three-patient clinical trial.
The details
Surgeons at Allegheny General Hospital implanted the 1.2-millimeter electrode to dampen specific brain signals linked to opioid cravings. Doctors continue to perform follow-up appointments to calibrate the strength of the device to optimize the patient's recovery.
Timeline
30 years ago, deep brain stimulation began being used to treat movement disorders.
In late August 2026, Jennifer King underwent her brain surgery.
September 28, 2026, is the date of the article publication.
The Big Picture
This study follows the established regulatory pathway for the FDA-approved deep brain stimulation clinical trial. While deep brain stimulation has been utilized for 30 years to treat movement disorders, this application marks a transition toward addressing behavioral health.
The study offers a potential alternative for patients who have failed to find relief through traditional evidence-based addiction therapies. Participants must commit to ongoing medical follow-up appointments to allow doctors to adjust the stimulation levels of the implant.
The takeaway
This trial highlights a shift in neurosurgical intervention toward treating severe chemical dependencies. It remains in the experimental stage as researchers seek their final participant to complete the small-scale study group.
Further reading
For additional context on addiction treatment research, visit the Substance Abuse section.
Source note: This article includes information reported by CBS News.
